Skin Cancer | Tumor

Things to Consider in Genetic Testing

October 25th 2019

A two-time cancer survivor learns more about pancreatic cysts and discusses the value and cautions of genetic testing.

Too Few Recognize the Dangers of a Common Skin Cancer: Squamous Cell Carcinoma

October 21st 2019

Cutaneous squamous cell carcinoma, caused by sun exposure or environmental toxins, is usually curable with surgery. Maybe that’s why many don’t realize that, if this cancer goes unchecked and untreated, it can grow, spread and become life-threatening.

Tick Tock: Your Time Is Your Life

October 5th 2019

A cancer survivor and clutter-clearing author shares autumnal time management tips.

Opdivo-Yervoy Combination Induces Long-Term Survival in Metastatic Melanoma

September 29th 2019

One in two patients with metastatic melanoma is alive five years following treatment with Opdivo plus Yervoy, according to long-term follow-up of the phase 3 CheckMate 067 trial.

IPMNs: A New Cancer Worry For An "Old" Survivor?

September 27th 2019

A two-time cancer survivor discusses her recently-discovered pancreatic cysts.

Fall Cleaning and Cancer 'Clutter'

September 21st 2019

This two-time cancer survivor and clutter-clearing author struggles more thoughtfully with clutter since cancer.

Survey Shows Americans Are Unaware of Common Type of Skin Cancer

September 19th 2019

A recent survey showed that most Americans do not know what cutaneous squamous cell carcinoma is and how severe the disease can be if it advances.

Cancer Survivorship And Age

September 14th 2019

A two-time cancer survivor explores her thoughts on aging.

'Listen to Your Mother' and Protect Your Skin

September 12th 2019

In this week’s episode of the “CURE Talks Cancer” podcast, we spoke with a skin cancer survivor who has dealt with many recurrences over the last 30 years and tells others to “listen to your mother” and protect your skin from the sun.

Secondhand Chances as a Cancer Survivor

August 30th 2019

Cancer can switch you to a different track but does not necessarily derail you, says a two-time cancer survivor.

Firsthand Tips for Dealing With Post-Cancer Fatigue

August 24th 2019

Nine years out from breast cancer and four years out from her melanoma, this cancer survivor still combats her fatigue.

This Melanoma Survivor Almost Got Burned, Again

August 16th 2019

There I was with my freshly darkened skin in the mirror (after a beautiful day out in the sun). What was I thinking? Oh yeah, I wasn’t thinking.

Human Connection After a Cancer Diagnosis

August 15th 2019

In this week’s episode of the “CURE Talks Cancer” podcast, we spoke with a melanoma survivor about the importance of community and human connection to build hope after a cancer diagnosis.

Friday Frontline: Cancer Updates, Research and Education on August 9, 2019

August 9th 2019

From hereditary cancer risk among twins to study findings in squamous cell carcinoma, here’s what is making headlines in the cancer space this week.

Six-Time Cancer Survivor Feels 'Damn Lucky'

August 6th 2019

Targeted Drug Combination Can Have Long-Lasting Results for Some With BRAF-Mutated Melanoma

August 2nd 2019

Figuring out whether to take targeted drugs or immunotherapy can be challenging for patients with metastatic melanoma that expresses a BRAF gene mutation, but there are rules of thumb that can help.

One Melanoma Survivor's Letter to Her Younger Self

June 27th 2019

In this week’s episode of “CURE Talks Cancer,” we spoke with a melanoma survivor who wishes she knew at diagnosis what her cancer journey would do for her – not to her.

Cancer and a Mid or Later-life Crisis?

June 11th 2019

A nine-year breast cancer survivor and five-year melanoma survivor shares her thoughts on cancer survivorship with a side of mid-life crisis.

Actor Who Realized Dreams After Melanoma Seeks to Inspire Survivors with His Story

June 5th 2019

In a talk to people affected by melanoma, Michael McGrady described reassessing his values after cancer and how it changed the course of his life.

Mixing and Matching: Multiple Treatments in Sequence or Combination are Key in Fighting Melanoma

May 29th 2019

Following surgery with medication, combining immunotherapies or targeted drugs and adding radiation to immunotherapy can improve effectiveness in treating various stages of melanoma.

To Build Healthy Futures, Survivors Must Pursue Monitoring After Melanoma Treatment

May 24th 2019

With greater longevity for survivors of melanoma comes the need to treat lingering side effects and monitor for cancer recurrences.

Keytruda Extends Progression-Free Survival in Patients with Merkel Cell Carcinoma

May 16th 2019

Immunotherapy may be giving hope to people living with rare skin cancer.

FDA Approves Keytruda for High-Risk, Advanced Melanoma

February 19th 2019

The Food and Drug Administration (FDA) approved Keytruda (pembrolizumab) – an immunotherapy agent – for the treatment of patients with resected, high-risk, stage 3 melanoma.

When Is It OK To Weed Out Cancer-Related Paper Clutter And Paraphernalia?

February 7th 2019

Here are tips for fellow cancer survivors to clear out cancer paraphernailia but keep important medical records.

Read Cancer Advice With Discernment

January 14th 2019

Two-time cancer survivor suggests a careful approach when researching your own cancer.

Online Tool May Mitigate Skin Cancer Risk

December 27th 2018

A web-based intervention may help reduce harmful UV exposure and skin cancer risk in young adults, according to recent research.

FDA Approves Keytruda for Merkel Cell Carcinoma

December 20th 2018

The Food and Drug Administration (FDA) granted accelerated approval to Keytruda (pembrolizumab) for the treatment of adult and pediatric patients with recurrent locally advanced or metastatic Merkel cell carcinoma, according to the agency.

Routine Surveillance Necessary for Young Patients with Posterior Uveal Melanoma

November 16th 2018

Young patients diagnosed with posterior uveal melanoma may have similar, if not worse, prognoses compared with the overall patient population.

Opdivo Shows Survival Benefit in Patients with Mutation-Specific Advanced Melanoma

November 15th 2018

Patients with BRAF wild-type advanced melanoma saw a survival benefit after treatment with Opdivo (nivolumab) compared with the chemotherapy agent dacarbazine.

Immunotherapy Combo Shows Durable Four-Year Survival Benefit in Advanced Melanoma

November 15th 2018

The combination use of two immunotherapy agents in the first-line setting helped patients with advanced melanoma live longer compared with treatment with either drug alone.